Clinical characteristics and risk factors of cerebral cavernous malformation-related epilepsy

Epilepsy Behav. 2023 Feb:139:109064. doi: 10.1016/j.yebeh.2022.109064. Epub 2023 Jan 12.

Abstract

Purpose: This study aimed to summarize the clinical characteristics and explore the risk factors for cerebral cavernous malformation (CCM)-related epilepsy (CRE).

Methods: We retrospectively analyzed the clinical data of patients with CCM in our cerebral vascular malformations database. Descriptive statistics were used to present the clinical characteristics of CRE patients. Patients were divided into a CRE and a non-CRE group according to clinical presentation. Binary logistic regression analysis was used to analyze the risk factors of CRE.

Results: A total of 199 patients with CCM confirmed by postoperative pathological examination were enrolled, 93 of whom were diagnosed with CRE, and 34 patients had drug-resistant epilepsy. The most common seizure type of CRE patients was focal to bilateral tonic-clonic seizure (FBTCS), followed by focal impaired awareness motor seizure. All CCM lesions were supratentorial, 97.8% of which involved the cerebral cortex, 86.0% of lesions had hemosiderin rim, and 50.5% of lesions were located in the temporal lobe. Binary logistic regression analysis indicated that CCM diagnosis age ≤ 44 years (odds ratio [OR] 2.79, p = 0.010), temporal lobe lesion location (OR = 9.07, p = 0.042), medial temporal lobe lesion (OR = 14.09, p = 0.002), cortical involvement of the lesion (OR = 32.77, p = 0.010), and hemosiderin rim around the lesion (OR = 16.48, p = 0.001) significantly increased the risk of CRE.

Conclusions: The most common seizure type of CRE was FBTCS. Those whose CCM diagnosis age was ≤ 44 years, having a temporal lobe lesion location, especially the medial temporal lobe lesion, cortical involvement, and hemosiderin rim around the lesion had a higher risk of developing CRE.

Keywords: Cerebral cavernous malformation; Epilepsy; Risk factor; Seizure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Epilepsy* / epidemiology
  • Epilepsy* / etiology
  • Epilepsy* / surgery
  • Hemangioma, Cavernous, Central Nervous System* / complications
  • Hemangioma, Cavernous, Central Nervous System* / diagnostic imaging
  • Hemangioma, Cavernous, Central Nervous System* / surgery
  • Hemosiderin
  • Humans
  • Retrospective Studies
  • Risk Factors
  • Seizures / complications
  • Treatment Outcome

Substances

  • Hemosiderin

Associated data

  • ChiCTR/ChiCTR1900024948